Dong-A sues Poolim Pharm over Stillen patent

Published: 2013-01-07 06:59:00
Updated: 2013-01-07 06:59:00
Dong-A Pharmaceutical is suing Poonglim Pharmaceutical for violating its patent rights of Stillen, one of Dong-A’s flagship products for treatment of gastritis.

Dong-A said Thursday Poonglim has violated patent rights by producing Stillen, of which the main ingredient is the same as that in Do...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.